SMTL ID : 1lxc.1

Crystal Structure of E. Coli Enoyl Reductase-NAD+ with a Bound Acrylamide Inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

homo-tetramer

Ligands

4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)

NAD.1: 21 residues within 4Å: Chain A: G.13, V.14, A.15, S.19, I.20, Q.40, C.63, D.64, V.65, S.91, I.92, G.93, L.144, S.145, K.163, A.189, G.190, P.191, I.192, T.194 Ligands: AYM.2 18 PLIP interactions: 18 interactions with chain A Hydrophobic interactions: A:I.20, A:A.189 Hydrogen bonds: A:G.13, A:S.19, A:I.20, A:Q.40, A:D.64, A:V.65, A:I.92, A:K.163, A:I.192, A:I.192 Water bridges: A:G.13, A:A.21, A:Q.40, A:S.91, A:I.92, A:G.93 NAD.3: 25 residues within 4Å: Chain B: G.13, V.14, A.15, S.19, I.20, Q.40, L.44, C.63, D.64, V.65, S.91, I.92, G.93, I.119, L.144, S.145, Y.146, K.163, A.189, G.190, P.191, I.192, T.194, L.195 Ligands: AYM.4 19 PLIP interactions: 19 interactions with chain B Hydrophobic interactions: B:I.20, B:Y.146, B:A.189 Hydrogen bonds: B:G.13, B:S.19, B:I.20, B:Q.40, B:D.64, B:V.65, B:I.92, B:G.93, B:K.163, B:I.192, B:I.192, B:T.194 Water bridges: B:A.21, B:Q.40, B:S.91, B:I.92 NAD.5: 21 residues within 4Å: Chain C: G.13, V.14, A.15, S.19, I.20, Q.40, C.63, D.64, V.65, S.91, I.92, G.93, L.144, S.145, K.163, A.189, G.190, P.191, I.192, T.194 Ligands: AYM.6 20 PLIP interactions: 20 interactions with chain C Hydrophobic interactions: C:I.20, C:A.189 Hydrogen bonds: C:G.13, C:S.19, C:I.20, C:Q.40, C:D.64, C:D.64, C:V.65, C:I.92, C:K.163, C:I.192, C:I.192, C:T.194 Water bridges: C:G.13, C:A.21, C:Q.40, C:S.91, C:I.92, C:G.93 NAD.7: 25 residues within 4Å: Chain D: G.13, V.14, A.15, S.19, I.20, Q.40, L.44, C.63, D.64, V.65, S.91, I.92, G.93, I.119, L.144, S.145, Y.146, K.163, A.189, G.190, P.191, I.192, T.194, L.195 Ligands: AYM.8 20 PLIP interactions: 20 interactions with chain D Hydrophobic interactions: D:I.20, D:Y.146, D:A.189 Hydrogen bonds: D:G.13, D:S.19, D:I.20, D:Q.40, D:D.64, D:D.64, D:V.65, D:I.92, D:G.93, D:K.163, D:I.192, D:I.192, D:T.194 Water bridges: D:A.21, D:Q.40, D:S.91, D:I.92

4 x AYM: 3-(6-AMINOPYRIDIN-3-YL)-N-METHYL-N-[(1-METHYL-1H-INDOL-2-YL)METHYL]ACRYLAMIDE(Non-covalent)

AYM.2: 13 residues within 4Å: Chain A: G.93, F.94, A.95, L.100, Y.146, P.154, N.155, Y.156, M.159, K.163, F.203, M.206 Ligands: NAD.1 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.100, A:N.155 Hydrogen bonds: A:A.95, A:A.95, A:Y.156 pi-Stacking: A:Y.156, A:Y.156 AYM.4: 11 residues within 4Å: Chain B: G.93, F.94, A.95, Y.146, I.153, P.154, N.155, Y.156, F.203, M.206 Ligands: NAD.3 6 PLIP interactions: 6 interactions with chain B Hydrophobic interactions: B:I.153, B:N.155 Hydrogen bonds: B:A.95, B:A.95 pi-Stacking: B:Y.156, B:Y.156 AYM.6: 13 residues within 4Å: Chain C: G.93, F.94, A.95, L.100, Y.146, P.154, N.155, Y.156, M.159, K.163, F.203, M.206 Ligands: NAD.5 6 PLIP interactions: 6 interactions with chain C Hydrophobic interactions: C:L.100, C:N.155 Hydrogen bonds: C:A.95, C:A.95 pi-Stacking: C:Y.156, C:Y.156 AYM.8: 11 residues within 4Å: Chain D: G.93, F.94, A.95, Y.146, I.153, P.154, N.155, Y.156, F.203, M.206 Ligands: NAD.7 7 PLIP interactions: 7 interactions with chain D Hydrophobic interactions: D:I.153, D:N.155 Hydrogen bonds: D:A.95, D:A.95, D:Y.156 pi-Stacking: D:Y.156, D:Y.156

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Miller, W.H. et al., Discovery of aminopyridine-based inhibitors of bacterial enoyl-ACP reductase (FabI). J.Med.Chem. (2002)

Release Date

2002-09-04

Peptides

ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADH]: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
A

D
B

ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADH]

Related Entries With Identical Sequence